Jane Henderson, Chief Financial Officer, conducted open market sales of Apogee Therapeutics ($APGE) shares 15 times over the last year, totaling $1.4 million, with her most recent sale on March 2, 2026. These sales rank 4,182nd among nearly 12,000 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions. She also sold Akero Therapeutics ($AKRO) shares once for $142,371 on August 12, 2025, ranking 9,050th. Henderson made no open market purchases in the past year.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 2000 | $85.00 | 179,371.0000 | 68,320,229 | 1.10% | 0.00% |
| March 2, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 300 | $68.27 | 183,071.0000 | 68,320,229 | 0.16% | 0.00% |
| March 2, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 406 | $71.66 | 181,371.0000 | 68,320,229 | 0.22% | 0.00% |
| March 2, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 994 | $70.45 | 181,777.0000 | 68,320,229 | 0.54% | 0.00% |
| March 2, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 300 | $69.43 | 182,771.0000 | 68,320,229 | 0.16% | 0.00% |
| Feb. 2, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 1108 | $66.15 | 183,471.0000 | 68,320,229 | 0.60% | 0.00% |
| Feb. 2, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 100 | $66.89 | 183,371.0000 | 68,320,229 | 0.05% | 0.00% |
| Feb. 2, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 792 | $65.21 | 184,579.0000 | 68,320,229 | 0.43% | 0.00% |
| Jan. 2, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 1920 | $74.13 | 191,451.0000 | 68,320,229 | 0.99% | 0.00% |
| Jan. 2, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | A | Stock Option (Right to Buy) | 83690 | $0.00 | 83,690.0000 | 68,320,229 | 9999.99% | 0.12% |
| Jan. 6, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 2000 | $80.00 | 185,371.0000 | 68,320,229 | 1.07% | 0.00% |
| Jan. 2, 2026 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 4080 | $75.20 | 187,371.0000 | 68,320,229 | 2.13% | 0.01% |
| Dec. 19, 2025 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 1500 | $80.00 | 193,371.0000 | 68,320,229 | 0.77% | 0.00% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | D | Common Stock | 9398 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | D | Stock Option (Right to Buy) | 26000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.03% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | D | Stock Option (Right to Buy) | 13000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | D | Stock Option (Right to Buy) | 13000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | D | Stock Option (Right to Buy) | 11797 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Dec. 4, 2025 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 1500 | $75.00 | 194,871.0000 | 68,320,229 | 0.76% | 0.00% |
| Nov. 25, 2025 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 1500 | $70.00 | 196,371.0000 | 68,320,229 | 0.76% | 0.00% |
| Nov. 14, 2025 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 2000 | $65.00 | 197,871.0000 | 68,320,229 | 1.00% | 0.00% |
| Nov. 11, 2025 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 1000 | $60.00 | 199,871.0000 | 68,320,229 | 0.50% | 0.00% |
| Aug. 19, 2025 | CARGO Therapeutics, Inc. | $CRGX | Henderson Jane | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 48,364,311 | 100.00% | 0.05% |
| Aug. 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | S | Common Stock | 3000 | $47.46 | 9,398.0000 | 79,620,128 | 24.20% | 0.00% |
| Aug. 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | M | Common Stock | 3000 | $7.01 | 12,398.0000 | 79,620,128 | 31.92% | 0.00% |
| Aug. 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | M | Stock Option (Right to Buy) | 3000 | $0.00 | 11,797.0000 | 79,620,128 | 20.27% | 0.00% |
| June 18, 2025 | CARGO Therapeutics, Inc. | $CRGX | Henderson Jane | Not found | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 46,052,368 | 9999.99% | 0.05% |
| June 3, 2025 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | A | Common Stock | 9398 | $0.00 | 9,398.0000 | 79,620,128 | 9999.99% | 0.01% |
| Dec. 9, 2024 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | A | Stock Option (Right to Buy) | 124962 | $0.00 | 124,962.0000 | 0 | 9999.99% | 0.00% |
| Aug. 23, 2024 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | S | Common Stock | 6000 | $48.26 | 200,871.0000 | 0 | 2.90% | 0.00% |
| June 8, 2024 | Akero Therapeutics, Inc. | $AKRO | Henderson Jane | Not found | A | Stock Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | CARGO Therapeutics, Inc. | $CRGX | Henderson Jane | Not found | A | Stock Option (Right to Buy) | 39402 | $0.00 | 39,402.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | CARGO Therapeutics, Inc. | $CRGX | Henderson Jane | Not found | A | Stock Option (Right to Buy) | 19785 | $0.00 | 19,785.0000 | 0 | 9999.99% | 0.00% |
| Dec. 18, 2023 | Apogee Therapeutics, Inc. | $APGE | Henderson Jane | Chief Financial Officer | A | Stock Option (Right to Buy) | 175345 | $0.00 | 175,345.0000 | 0 | 9999.99% | 0.00% |